Zeng H, Rong X Y, Wang Y, Guo X Y
Department of Anesthesiology, Peking University, Third Hospital, Beijing 100191, China.
Zhonghua Yi Xue Za Zhi. 2017 Nov 14;97(42):3329-3333. doi: 10.3760/cma.j.issn.0376-2491.2017.42.012.
To explore the key points of anesthetic management for renal cell carcinoma combined with inferior vena cava (IVC) tumor thrombus. Twenty-seven cases of renal cell carcinoma with inferior vena cava (IVC) tumor thrombus underwent radical nephrectomy and inferior caval venous thrombectomy were reviewed retrospectively during January 2014 to January 2017 in our hospital.Analyzed data includs demographics, classification of tumor, perioperative anesthetic management and monitoring approaches, IVC clamping time , vital signs during cardiopulmonary bypass(CPB), estimated blood loss (EBL), usage of blood products, hospitalization time and ICU time , as well as postoperative outcomes. Clinical staging revealed 5 patients(18.5%) with classⅠtumor thrombus, 11 patients(40.7%) with levelⅡtumor thrombus, 6 patients (22.2%) with level Ⅲ tumor thrombus and 5 patients (18.5%) with level Ⅳ tumor thrombus. All patients had underwent a balanced general anesthesia technique with volatile agents, opioids and muscle relaxants. In addition to standard ASA monitors, all patients had direct arterial pressure and central venous pressure monitoring, and blood warming and infusing system. TEE was utilized in 9(33.3%)patients and in which contains all 5 patients(100%)with level Ⅳ tumor thrombus. Intraoperative TEE guidance resulted in a significant surgical plan modification in 1 patient(11.1%). Compared to patients with class Ⅰ(313 (136, 346) min), classⅡ(302(245, 393)min)and classⅢthrombus tumor(391(272, 505)min), patients with Class Ⅳ had longer operating time (525(481, 647)min, <0.05). Compared to patients with Class Ⅰ(600(500, 850)ml), Class Ⅱ(1 700(750, 3 000)ml), and Class Ⅲ(1 775(1 500, 3 000)ml), patients with Class Ⅳ had more blood loss(4 000(2 000, 7 000)ml, <0.05). The clamping time of Class Ⅰ, Class Ⅱ and Class Ⅲ was 8(8, 9)min, 20(13, 26)min and 10(6, 25)min, respectively, and there is no significant difference (>0.05) within theses group. The probability of pumping norepinephrine of Class Ⅰ(8(8, 9)min), Class Ⅱ(20(13, 26)min), and Class Ⅲ(10(6, 25)min)had no significant difference (χ(2)=5.147, >0.05). Perioperative mortality was 7.4%. The anesthetic management of Inferior vena cava (IVC) tumor thrombus is rather challenging.The preoperative evaluation with accurate classification of the tumor and the intraoperative intense monitoring of vital signs with appropriate reaction are the key points of anesthetic management for this kind of surgery.
探讨肾细胞癌合并下腔静脉(IVC)瘤栓麻醉管理的要点。回顾性分析2014年1月至2017年1月在我院接受根治性肾切除术及下腔静脉血栓切除术的27例肾细胞癌合并下腔静脉瘤栓患者的资料。分析的数据包括人口统计学资料、肿瘤分类、围手术期麻醉管理及监测方法、下腔静脉阻断时间、体外循环(CPB)期间的生命体征、估计失血量(EBL)、血制品使用情况、住院时间和重症监护病房(ICU)时间以及术后结果。临床分期显示,5例(18.5%)为Ⅰ级瘤栓,11例(40.7%)为Ⅱ级瘤栓,6例(22.2%)为Ⅲ级瘤栓,5例(18.5%)为Ⅳ级瘤栓。所有患者均采用挥发性麻醉药、阿片类药物和肌肉松弛剂的平衡全身麻醉技术。除标准的美国麻醉医师协会(ASA)监测外,所有患者均进行直接动脉压和中心静脉压监测,并使用血液加温输注系统。9例(33.3%)患者使用了经食管超声心动图(TEE),其中包括所有5例(100%)Ⅳ级瘤栓患者。术中TEE引导导致1例(11.1%)患者的手术方案发生重大改变。与Ⅰ级(313(136,346)分钟)、Ⅱ级(302(245,393)分钟)和Ⅲ级瘤栓肿瘤患者(391(272,505)分钟)相比,Ⅳ级患者的手术时间更长(525(481,647)分钟,<0.05)。与Ⅰ级(600(500,850)毫升)、Ⅱ级(1700(750,3000)毫升)和Ⅲ级(1775(1500,3000)毫升)患者相比,Ⅳ级患者的失血量更多(4000(2000,7000)毫升,<0.05)。Ⅰ级、Ⅱ级和Ⅲ级的阻断时间分别为8(8,9)分钟、20(13,26)分钟和10(6,25)分钟,这些组间无显著差异(>0.05)。Ⅰ级(8(8,9)分钟)、Ⅱ级(20(13,26)分钟)和Ⅲ级(10(6,25)分钟)使用去甲肾上腺素的概率无显著差异(χ(2)=5.147,>0.05)。围手术期死亡率为7.4%。下腔静脉瘤栓的麻醉管理颇具挑战性。术前准确的肿瘤分类评估以及术中对生命体征的密切监测并做出适当反应是此类手术麻醉管理的关键要点。